Validation and comparison of prognostic scales in Chinese patients with ischemic stroke: a prospective study from CATIS

CONCLUSION: : The ASTRAL score had higher efficacy than the SPAN-100 and THRIVE scores in predicting 2-year adverse outcomes among Chinese patients with ischemic stroke, suggesting that it could be a valuable risk assessment tool for the 2-year prognosis of such patients.PMID:34431455 | DOI:10.1080/01616412.2021.1959775

Source: Neurological Research - August 25, 2021 Category: Neurology Authors: Kaixin Zhang Zhengbao Zhu Bizhong Che Xiaoqing Bu Tian Xu Chongke Zhong Aili Wang Hao Peng Daoxia Guo Xiaowei Zheng Tan Xu Jing Chen Yonghong Zhang Jiang He Source Type: research